menu
{ "item_title" : "Polypharmacy in Psychiatry Practice, Volume I", "item_author" : [" Michael S. Ritsner "], "item_description" : "Although monotherapy is generally recommended as the treatment of choice, treatment resistance of patients with psychosis, cognitive, mood and anxiety disorders represents a significant clinical problem. In this context, augmentation and combination strategies are commonly employed to address this problem. Although multiple medication use common in psychiatric practice, reasons, efficacy and safety for polypharmacy, and augmentative strategies have remained unclear. It remains unclear if there is an evidence base to support polypharmacy. Furthermore, excessive and inappropriate use of psychotropic medications has been recognized as a public health problem. This volume set is the first comprehensive, clinically oriented, reference on the multiple medication use to treat psychotic, cognitive, mood and anxiety disorders.", "item_img_path" : "https://covers2.booksamillion.com/covers/bam/9/40/075/804/9400758049_b.jpg", "price_data" : { "retail_price" : "199.99", "online_price" : "199.99", "our_price" : "199.99", "club_price" : "199.99", "savings_pct" : "0", "savings_amt" : "0.00", "club_savings_pct" : "0", "club_savings_amt" : "0.00", "discount_pct" : "10", "store_price" : "" } }
Polypharmacy in Psychiatry Practice, Volume I|Michael S. Ritsner

Polypharmacy in Psychiatry Practice, Volume I : Multiple Medication Use Strategies

local_shippingShip to Me
In Stock.
FREE Shipping for Club Members help

Overview

Although monotherapy is generally recommended as the treatment of choice, treatment resistance of patients with psychosis, cognitive, mood and anxiety disorders represents a significant clinical problem. In this context, augmentation and combination strategies are commonly employed to address this problem. Although multiple medication use common in psychiatric practice, reasons, efficacy and safety for polypharmacy, and augmentative strategies have remained unclear. It remains unclear if there is an evidence base to support polypharmacy. Furthermore, excessive and inappropriate use of psychotropic medications has been recognized as a public health problem. This volume set is the first comprehensive, clinically oriented, reference on the multiple medication use to treat psychotic, cognitive, mood and anxiety disorders.

This item is Non-Returnable

Details

  • ISBN-13: 9789400758049
  • ISBN-10: 9400758049
  • Publisher: Springer
  • Publish Date: February 2013
  • Dimensions: 9.2 x 6.2 x 0.9 inches
  • Shipping Weight: 1.63 pounds
  • Page Count: 287

Related Categories

You May Also Like...

    1

BAM Customer Reviews